Importantly, the majority of DysF pathogenic mutations, responsible for dysferlinopathies in humans, occur within the DysF domain (Sula et al., 2014; Izumi et al., 2020). This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.